Literature DB >> 31555560

Comparison and outcomes of nonobstructive azoospermia patients with different etiology undergoing MicroTESE and ICSI treatments.

Xiangfeng Chen1,2,3, Yi Ma1,2, Shasha Zou3, Siqi Wang3, Jin Qiu3, Qian Xiao3, Liang Zhou4, Ping Ping1,2.   

Abstract

BACKGROUND: The purpose of the study was to compare clinical, laboratory, histological features, microdissection testicular sperm extraction (MicroTESE) and intracytoplasmic sperm injection (ICSI) treatment outcomes of nonobstructive azoospermia (NOA) patients of various etiologies, and to investigate ICSI outcomes using fresh and frozen thawed sperms from MicroTESE, so to explore an optimal MicroTESE-ICSI procedure for NOA couples.
METHODS: A retrospective analysis was made in 595 NOA patients undergoing MicroTESE from January 2013 to December 2017. The men were classified into six groups based on etiology. Patients' age, history, hormone profile, testis volume, testicular histology, sperm retrieval, fertile and pregnancy outcomes of ICSI were included for analysis.
RESULTS: A total of 595 NOA patients were included in this study, with 446 (75.0%) were idiopathic NOA, 66 (11.1%) were Klinefelter syndrome (KS), 34 (5.7%) with microdeletion of the AZFc, 33 (5.5%) cases had the history of cryptorchidism, 13 (2.2%) had a history of mumps orchitis, and 3 (0.5%) cases underwent chemotherapy. The overall sperm retrieval rate (SRR) was 40.3% (240/595), SRR of the cryptorchidism (84.8%, 28/33) and mumps orchitis (84.6%, 11/13) groups were much higher than that of other groups, the SRR of idiopathic group was the lowest (31.8%, 142/446). One hundred and ninety-eight ICSI cycles utilizing MicroTESE sperm were retrospectively analyzed, including 155 fresh MicroTESE ICSI cycles and 43 frozen-thawed MicroTESE ICSI cycles. Fertilization rate, cleavage rate, and clinical pregnancy rate of fresh sperm group were slightly higher than those in frozen thawed MicroTESE sperm group, but high qualified embryo rate of fresh sperm group was lower than frozen thawed group. The differences were of no statistical meaning.
CONCLUSIONS: Etiology may be an effective prognostic factor for SRR in NOA patients. NOA of definite etiology, such as cryptorchidism, has high SRR, while idiopathic NOA, the most common type of NOA, has the lowest SRR. Using of frozen thawed sperm from MicroTESE had similar pregnant outcome to that of fresh sperm, so cryopreservation of testicular sperm seems to be more suitable and of great benefit in these cases and good results can also be expected when oocyte retrieval and ICSI are not performed at the same time.

Entities:  

Keywords:  Microdissection testicular sperm extraction (MicroTESE); intracytoplasmic sperm injection (ICSI); nonobstructive azoospermia (NOA); sperm retrieval

Year:  2019        PMID: 31555560      PMCID: PMC6732089          DOI: 10.21037/tau.2019.04.08

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  29 in total

1.  Serum levels of inhibin B and follicle-stimulating hormone may predict successful sperm retrieval in men with azoospermia who are undergoing testicular sperm extraction.

Authors:  Claudia Bohring; Immo Schroeder-Printzen; Wolfgang Weidner; Walter Krause
Journal:  Fertil Steril       Date:  2002-12       Impact factor: 7.329

2.  Use of frozen-thawed testicular sperm for intracytoplasmic sperm injection.

Authors:  W Küpker; P N Schlegel; S Al-Hasani; P Fornara; R Johannisson; J Sandmann; T Schill; M Bals-Pratsch; M Ludwig; K Diedrich
Journal:  Fertil Steril       Date:  2000-03       Impact factor: 7.329

3.  Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction.

Authors:  Ranjith Ramasamy; Neda Yagan; Peter N Schlegel
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

4.  Microsurgical TESE and the distribution of spermatogenesis in non-obstructive azoospermia.

Authors:  S J Silber
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

5.  In vitro fertilization outcomes after intracytoplasmic sperm injection with fresh or frozen-thawed testicular spermatozoa.

Authors:  H Habermann; R Seo; J Cieslak; C Niederberger; G S Prins; L Ross
Journal:  Fertil Steril       Date:  2000-05       Impact factor: 7.329

6.  Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia.

Authors:  V Vernaeve; H Tournaye; J Schiettecatte; G Verheyen; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

7.  Testis sperm extraction and intracytoplasmic sperm injection guided by prior fine-needle aspiration mapping in patients with nonobstructive azoospermia.

Authors:  P J Turek; C R Givens; E D Schriock; M V Meng; R A Pedersen; J Conaghan
Journal:  Fertil Steril       Date:  1999-03       Impact factor: 7.329

8.  Can biological or clinical parameters predict testicular sperm recovery in 47,XXY Klinefelter's syndrome patients?

Authors:  V Vernaeve; C Staessen; G Verheyen; A Van Steirteghem; P Devroey; H Tournaye
Journal:  Hum Reprod       Date:  2004-04-07       Impact factor: 6.918

9.  Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism.

Authors:  Jay D Raman; Peter N Schlegel
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

10.  Testicular sperm extraction in azoospermic men submitted to bilateral orchidopexy.

Authors:  L Negri; E Albani; M DiRocco; G Morreale; P Novara; P E Levi-Setti
Journal:  Hum Reprod       Date:  2003-12       Impact factor: 6.918

View more
  9 in total

Review 1.  Microdissection testicular sperm extraction (micro-TESE) in men with infertility due to nonobstructive azoospermia: summary of current literature.

Authors:  Arnold P P Achermann; Thairo A Pereira; Sandro C Esteves
Journal:  Int Urol Nephrol       Date:  2021-08-19       Impact factor: 2.370

2.  Clinical Outcomes and Live Birth Rate Resulted From Microdissection Testicular Sperm Extraction With ICSI-IVF in Non-Obstructive Azoospermia: A Single-Center Cohort Study.

Authors:  Yu Lan; Haiyan Zheng; Xin Fu; Tianwen Peng; Chen Liao; Jianan Liu; Min Liu; Geng An
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 3.  Mutational landscape of DNAH1 in Chinese patients with multiple morphological abnormalities of the sperm flagella: cohort study and literature review.

Authors:  Wen Yu; Miao An; Yang Xu; Qingqiang Gao; Mujun Lu; Yingying Li; Li Zhang; Hongxiang Wang; Zhipeng Xu
Journal:  J Assist Reprod Genet       Date:  2021-04-30       Impact factor: 3.357

Review 4.  Predictors of testicular sperm retrieval in patients with non-obstructive azoospermia: a review.

Authors:  Lin Qi; Ya P Liu; Nan N Zhang; Ying C Su
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

Review 5.  Prediction Models for Successful Sperm Retrieval in Patients with Non-Obstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: Is There Any Room for Further Studies?

Authors:  Ettore Caroppo; Giovanni Maria Colpi
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

6.  Clinical outcomes of 77 TESE treatment cycles in non-mosaic Klinefelter syndrome patients.

Authors:  Pedro Barros; Mariana Cunha; Alberto Barros; Mário Sousa; Sofia Dória
Journal:  JBRA Assist Reprod       Date:  2022-08-04

7.  Comparison of intracytoplasmic sperm injection (ICSI) outcomes in infertile men with spermatogenic impairment of differing severity.

Authors:  Ping Ping; Zhong Zheng; Yi Ma; Sha-Sha Zou; Xiang-Feng Chen
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

Review 8.  Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction.

Authors:  Caroline Kang; Nahid Punjani; Peter N Schlegel
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

9.  PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome.

Authors:  Jing Tong; Xiao-Ming Zhao; An-Ran Wan; Ting Zhang
Journal:  Asian J Androl       Date:  2021 Nov-Dec       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.